- About Us
- Nano-Social Network
- Nano Consulting
- My Account
September 24th, 2007
Preserving organs and killing cancer cells with products that employ nanotechnology—the emerging science of manufacturing at the molecular level—were the hot topics last week when the New Jersey Technology Council sponsored a forum on one of the latest trends in biomedical research.
The Philadelphia gathering of 25 executives, scientists and other members of the health care community heard how nanotechnology is being used to make and develop biomedical devices and drugs. The science, which takes place on the scale of one billionth of a meter, is slowly leaving federally funded laboratories and making its way into fields ranging from retail to medicine.
Panelist Joseph Fischer, chairman and CEO of Lifeblood Medical Inc. in Adelphia, says his company employs nanotechnology to make Lifor, a liquid that preserves organs used for transplants, and to make LiforCell, which preserves tissues and cells used in laboratory experiments. He says the U.S. Navy is testing Lifor for limb preservation.
|Related News Press|
New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017
Strength of hair inspires new materials for body armor January 18th, 2017
Self-assembling particles brighten future of LED lighting January 18th, 2017
Nanometrics to Present at the 19th Annual Needham Growth Conference December 22nd, 2016